Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolution of Luteal Progesteronemia in a Modified Natural Cycle
NCT07028710Recruiting
- Sponsor
- CHU Montpellier
- Start
- Jan 2026
- Primary completion
- Jun 2028
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Open-label, single-arm trial of human chorionic gonadotropin in luteal phase deficiency (LPD), sponsored by CHU Montpellier. Primary endpoint: Serum Progesterone Level on Day 3 After hCG Trigger. Started Jan 2026; status: recruiting.
02
Drugs
human chorionic gonadotropin
03
Conditions
luteal phase deficiency (LPD)
Beyond the preview
Go deeper on NCT07028710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07028710.